There is a specific kind of silence that occurs only when there is bad news. This type of silence isn’t peaceful or calm. It is…
Myeloma
Medications designed to block a signaling protein called NOTCH3 — which plays a key role in the function and survival of cells in the body…
I’m writing this a few days after the end of ASH 2025, the annual meeting of the American Society of Hematology. As I mentioned…
VV169, an experimental cellular therapy being developed by Vyriad to treat myeloma, is expected to enter clinical testing in 2026, the…
This morning, while I was making myself a cup of coffee, I saw my reflection in the curved, stainless steel surface of the kettle as…
Johnson & Johnson (J&J) is asking the U.S. Food and Drug Administration (FDA) to approve a combination of two medications, Tecvayli (teclistamab) and…
A caregiver’s energy is a rare currency. When we spend it, we’re not doing so in single, large transactions. Instead, we’re making thousands of tiny…
Most people with hard-to-treat myeloma were still alive and free from disease progression two years after treatment with anito-cel (anitocabtagene autoleucel), an experimental cell…
As I write this, yesterday was Tuesday. Perhaps it was a great day for someone who got a promotion or received a gift. But for…
Most myeloma patients who started treatment at the Berenson Cancer Center — a clinic in California that specializes in myeloma care — lived…
Recent Posts
- Partners to collect real-world data to speed care for kids with AML
- Study finds home transfusions safe in hospice care for blood cancer
- Small acts of defiance are the ways we push back against disease
- Under-the-skin myeloma treatment linked to better survival in study
- Add-on therapy shows promise for hard-to-treat AML